Terms: = Endocrine gland cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD
356 results:
1. ABCD1 as a Novel Diagnostic Marker for Solid Pseudopapillary Neoplasm of the Pancreas.
Liu YA; Liu Y; Tu J; Shi Y; Pang J; Huang Q; Wang X; Lin Z; Zhao Y; Wang W; Peng J; Wu W
Am J Surg Pathol; 2024 May; 48(5):511-520. PubMed ID: 38567813
[TBL] [Abstract] [Full Text] [Related]
2. CRISPR du-HITI an attractive approach to targeting Long Noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell.
Moradi Z; Kazemi M; Jamshidi-Khalifelou R; Bahramnia V; Esfandmaz F; Rahnavard R; Moradgholi B; Piri-Gharaghie T
Funct Integr Genomics; 2024 Mar; 24(2):61. PubMed ID: 38507114
[TBL] [Abstract] [Full Text] [Related]
3. Dual-energy computed tomography in a multiparametric regression model for diagnosing lymph node metastases in pancreatic ductal adenocarcinoma.
Li S; Jiang D; Jiang L; Yan S; Liu L; Ruan G; Zhou X; Zhuo S
Cancer Imaging; 2024 Mar; 24(1):38. PubMed ID: 38504330
[TBL] [Abstract] [Full Text] [Related]
4. Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathway.
Wang H; Xu YH; Guo Y
J Ovarian Res; 2024 Feb; 17(1):50. PubMed ID: 38395907
[TBL] [Abstract] [Full Text] [Related]
5. Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells.
Kaçaroğlu D; Yaylacı S; Gurbuz N
Cancer Med; 2024 Jan; 13(2):e6964. PubMed ID: 38379331
[TBL] [Abstract] [Full Text] [Related]
6. Transcriptomic Analysis of the Aged Nulliparous Mouse Ovary Suggests a Stress State That Promotes Pro-Inflammatory Lipid Signaling and Epithelial Cell Enrichment.
Chacón C; Mounieres C; Ampuero S; Urzúa U
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203684
[TBL] [Abstract] [Full Text] [Related]
7. SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma.
Teveroni E; Di Nicuolo F; Vergani E; Oliva A; Vodola EP; Bianchetti G; Maulucci G; De Spirito M; Cenci T; Pierconti F; Gulino G; Iavarone F; Urbani A; Milardi D; Pontecorvi A; Mancini F
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069214
[TBL] [Abstract] [Full Text] [Related]
8. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Daly MB; Pal T; Maxwell KN; Churpek J; Kohlmann W; AlHilli Z; Arun B; Buys SS; Cheng H; Domchek SM; Friedman S; Giri V; Goggins M; Hagemann A; Hendrix A; Hutton ML; Karlan BY; Kassem N; Khan S; Khoury K; Kurian AW; Laronga C; Mak JS; Mansour J; McDonnell K; Menendez CS; Merajver SD; Norquist BS; Offit K; Rash D; Reiser G; Senter-Jamieson L; Shannon KM; Visvanathan K; Welborn J; Wick MJ; Wood M; Yurgelun MB; Dwyer MA; Darlow SD
J Natl Compr Canc Netw; 2023 Oct; 21(10):1000-1010. PubMed ID: 37856201
[TBL] [Abstract] [Full Text] [Related]
9. Smoking and alcohol consumption with the risk of 11 common otolaryngological diseases: a bidirectional Mendelian randomization.
Wang X; Bi Y; Liu G; Wang W; Cui H
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5615-5623. PubMed ID: 37752250
[TBL] [Abstract] [Full Text] [Related]
10. Ranitidine Use and Incident cancer in a Multinational Cohort.
You SC; Seo SI; Falconer T; Yanover C; Duarte-Salles T; Seager S; Posada JD; Shah NH; Nguyen PA; Kim Y; Hsu JC; Van Zandt M; Hsu MH; Lee HL; Ko H; Shin WG; Pratt N; Park RW; Reich CG; Suchard MA; Hripcsak G; Park CH; Prieto-Alhambra D
JAMA Netw Open; 2023 Sep; 6(9):e2333495. PubMed ID: 37725377
[TBL] [Abstract] [Full Text] [Related]
11. [
Guo X; Chen L; Lü Q; DU R; Luo Q; Zhang Y; Bian H; Han L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1315-1321. PubMed ID: 37712267
[TBL] [Abstract] [Full Text] [Related]
12. Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC).
Fernández Madrigal L; Rodríguez Garcés MY; Jiménez Ruiz FJ
Curr Probl Cancer; 2023 Dec; 47(6):101008. PubMed ID: 37704491
[TBL] [Abstract] [Full Text] [Related]
13. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis.
Khoury T; Sbeit W; Fusaroli P; Campana D; Brighi N; Napoleon B; Lisotti A
Dig Endosc; 2024 Apr; 36(4):395-405. PubMed ID: 37702096
[TBL] [Abstract] [Full Text] [Related]
14. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
[TBL] [Abstract] [Full Text] [Related]
15. Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian cancer.
Desai NV; Barrows ED; Nielsen SM; Hatchell KE; Anderson MJ; Haverfield EV; Herrera B; Esplin ED; Lucassen A; Tung NM; Isaacs C
JCO Precis Oncol; 2023 Aug; 7():e2200695. PubMed ID: 37535880
[TBL] [Abstract] [Full Text] [Related]
16. Role of computed tomography in predicting adrenal adenomas with cortisol hypersecretion.
Kim CK; Kang KA; Oh YL; Park SY
Br J Radiol; 2023 Sep; 96(1149):20221032. PubMed ID: 37393525
[TBL] [Abstract] [Full Text] [Related]
17. Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells.
Simbolo M; Silvestris N; Malleo G; Mafficini A; Maggino L; Cocomazzi A; Veghini L; Mombello A; Pezzini F; Sereni E; Martelli FM; Gkountakos A; Ciaparrone C; Piredda ML; Ingravallo G; Paolino G; Nappo F; Rapposelli IG; Frassinetti L; Saragoni L; Lonardi S; Pea A; Paiella S; Fassan M; Brunetti O; Cingarlini S; Salvia R; Milella M; Corbo V; Lawlor RT; Scarpa A; Luchini C
Mod Pathol; 2023 Sep; 36(9):100251. PubMed ID: 37355152
[TBL] [Abstract] [Full Text] [Related]
18. A comprehensive study on surveillance outcomes of a male population followed at a hereditary breast cancer high-risk consultation at a Portuguese tertiary hospital.
Oliveira MJ; Costa S; Magalhães A; Garrido L; Peleteiro B; Fougo JL; Castedo S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11145-11156. PubMed ID: 37347260
[TBL] [Abstract] [Full Text] [Related]
19. Five-year Outcome Between Radiofrequency Ablation vs Surgery for Unilateral Multifocal Papillary Thyroid Microcarcinoma.
Yan L; Yang Z; Li Y; Li X; Xiao J; Jing H; Luo Y
J Clin Endocrinol Metab; 2023 Nov; 108(12):3230-3238. PubMed ID: 37318878
[TBL] [Abstract] [Full Text] [Related]
20. Dual epigenetic changes in diabetes mellitus-associated pancreatic ductal adenocarcinoma correlate with downregulation of E-cadherin and worsened prognosis.
Hara Y; Mizukami H; Yamazaki K; Yamada T; Igawa A; Takeuchi Y; Sasaki T; Kushibiki H; Murakami K; Kudoh K; Ishido K; Hakamada K
J Pathol Clin Res; 2023 Sep; 9(5):354-366. PubMed ID: 37246239
[TBL] [Abstract] [Full Text] [Related]
[Next]
